Cara Therapeutics | CARA - Ebitda





Ebitda تغيير تاريخ
Acadia Pharmaceuticals USD -1.62M 21.94M 2026-03
Alterity Therapeutics Limited AUD -7.72M 2.99M 2023-06
Cara Therapeutics USD -2.39M 3.16M 2025-03
Cassava Sciences USD -11.73M 33.44M 2025-09
Chugai Pharma JPY 158.77B 10.24B 2026-03
Cipla INR 14.03B 4.48B 2026-06
Clal Biotechnology ILS -5.3M 2.09M 2022-12
Compugen USD -9.02M 1.12M 2026-03
CSL USD 3.13B 1.17B 2025-12
Grifols EUR 482.04M 7.04M 2025-09
Halozyme Therapeutics USD 328.81M 109.24M 2026-06
J&J USD 8.27B 1.08B 2026-03
Neurocrine Biosciences USD 193.3M 25.1M 2026-03
Pacira USD 48.67M 8.43M 2026-06
Pfizer USD 6.01B 18M 2026-06
RedHill Biopharma USD 2.69M 108.46M 2023-06
Supernus Pharmaceuticals USD 31.6M 2.37M 2026-06
Vanda Pharmaceuticals USD -8.31M 2.37M 2024-12